Mark Morgan's Lab
@M_MorganLab
Receptor Dynamics in Cancer Laboratory / Institute of Systems, Molecular & Systems Biology / University of Liverpool, UK
You might like
Very excited to share our latest paper describing crosstalk between αvβ6 integrin & HER2 in breast cancer invasion & drug resistance. Great work by @HJMald & many others science.org/doi/10.1126/sc… @ScienceAdvances @LivUniISMIB @AdamHurlstone Many thanks to @BCCare @NorthWestCancer
NEWS | New insights in breast cancer progression and drug resistance ➡️ bit.ly/3OLKIhb #CancerResearch | #TeamLivUni
Look at the amazing speaker list for Adhere2 next September! This is going to be an excellent meeting, in beautiful Zadar, Croatia. event.fourwaves.com/adhere2/pages/…
event.fourwaves.com
2nd International Conference Focused on Cell Adhesion - ADHERE 2
2nd International Conference Focused on Cell Adhesion - ADHERE 2
5) Components of the trafficking regulatory subnetwork are highly expressed in HER2+ breast cancers expressing high levels of αVβ6.
4) RAB5, RAB7A, and GDI2 differentially regulate invasion and αVβ6 integrin-mediated TGFβ activation, but this mechanism is uncoupled by trastuzumab resistance, rendering cells unresponsive to αVβ6, HER2 or TGFβ-Receptor inhibition.
2) Components of the trafficking regulatory subnetwork mediate direct crosstalk between αVβ6 and HER2, affecting receptor trafficking and signalling. 3) Trastuzumab resistance disrupts αVβ6-mediated control of HER2 endocytosis and signalling.
We show that: 1) Integrin αVβ6 recruits HER2 and a RAB5/RAB7A/GDI2 trafficking regulatory subnetwork. This recruitment is enhanced by exposure to the HER2-trageting drug trastuzumab, but dysregulated following acquired trastuzumab resistance.
Very excited to share our new paper on Talin binding to Amyloid Precursor Protein indicating a new way to think about Alzheimer's Disease. It has the most provocative discussion section we have ever written :) royalsocietypublishing.org/doi/10.1098/rs…
Excited to share that our latest paper on the crosstalk between integrin αVβ6 and HER2 in HER2+ breast cancer is OUT! @M_MorganLab @LivUniCancer @ScienceAdvances @LivUniISMIB #BreastCancer #Trastuzumab science.org/doi/10.1126/sc…
Great to meet you face to face for the first time @M_MorganLab & thank you for a great talk @LivCancerRes #LCR121! So much opportunity for #collaboration in tumour micro-environment and #immuno-oncology studies across @LivUniISMIB @livuniHLS @livuninews @LivHPartners
Dr Muhammad Awais from @LivUniCancer brought pancreatic research to Liverpool College for a Role Model Day👩🔬encouraging year 5 pupils to consider a career in science! Lab coats & origami added fun and culture to the day🥼tinyurl.com/2m45xpc9
United States Trends
- 1. Araujo 119K posts
- 2. Chelsea 438K posts
- 3. Estevao 107K posts
- 4. Ferran 56.5K posts
- 5. Barcelona 322K posts
- 6. Yamal 92.9K posts
- 7. Rashford 21.3K posts
- 8. #CHEBAR 11.8K posts
- 9. Enzo 45.6K posts
- 10. Cucurella 40.5K posts
- 11. Kounde 27.8K posts
- 12. Flick 29.3K posts
- 13. Godzilla 23.1K posts
- 14. Rush Hour 4 16.8K posts
- 15. #AskTems 4,207 posts
- 16. Happy Thanksgiving 23.6K posts
- 17. Sonny Gray 8,666 posts
- 18. Pedri 42.8K posts
- 19. Balde 9,772 posts
- 20. Oklahoma State 2,676 posts
Something went wrong.
Something went wrong.